Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
about
Systematic review of therapy for neurogenic detrusor overactivityAn integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction.Controversy over the pharmacological treatments of storage symptoms in spinal cord injury patients: a literature overview.An overview on mixed action drugs for the treatment of overactive bladder and detrusor overactivity.Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.Pharmacotherapy for Pediatric Neurogenic Bladder.[Hyperthermia in spina bifida patients treated with oxybutynin].Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study.Treatment outcomes according to neuropathic bladder sphincter dysfunction type after treatment of oxybutynin chloride in children with myelodysplasia.The effects of long-term medical treatment combined with clean intermittent catheterization in children with neurogenic detrusor overactivity.
P2860
Q35347758-D5E99583-C60F-4B81-B9F8-6348788468C6Q37641104-C8DB4290-69DE-48F2-8335-439C3CDC9684Q37951376-513A6B11-AC13-48AF-AA2C-E86E333DB64FQ38024986-3F5747C4-1A3A-4FD8-8CC8-5030D5E08591Q38071594-2A422A7B-43FA-418B-92CD-F0AE0B8199ABQ39437361-27447AD6-088F-46AA-906C-C5D857F2FCD0Q40283478-4EF0310F-1B97-4032-AA41-40CB77954947Q43225326-A52293BC-9D33-4CED-911D-C700FA447981Q43954425-D402ACFD-68D2-4050-8FF6-720B4C9F46D4Q51167569-FC5FC9D9-BD08-40AF-82EB-2A1EA51FD162
P2860
Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Propiverine vs oxybutynin for ...... re observational cohort study.
@en
Propiverine vs oxybutynin for ...... re observational cohort study.
@nl
type
label
Propiverine vs oxybutynin for ...... re observational cohort study.
@en
Propiverine vs oxybutynin for ...... re observational cohort study.
@nl
prefLabel
Propiverine vs oxybutynin for ...... re observational cohort study.
@en
Propiverine vs oxybutynin for ...... re observational cohort study.
@nl
P2093
P1433
P1476
Propiverine vs oxybutynin for ...... re observational cohort study.
@en
P2093
Andreas Niedeggen
Burghard Domurath
Daniela Schultz-Lampel
Gerd Mürtz
Gerhard Strugala
Heinrich Schulte-Baukloh
Helmut Madersbacher
Iris Körner
Joseph Nounla
Jürgen Pannek
P304
P356
10.1111/J.1464-410X.2008.08093.X
P50
P577
2008-10-24T00:00:00Z